Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
04:15pm, Monday, 12'th May 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that shareholders overwhelmingly approved its previously announced external manager acquisition, with 99.9%
Royalty Pharma: Again, Guidance Raised, Buy Confirmed
09:18pm, Sunday, 11'th May 2025
Royalty Pharma reported 12% growth in Q1 royalty receipts, driven by Vertex, GSK, and Roche, with adjusted EBITDA reaching $738 million. The company raised its 2025 Portfolio Receipts guidance to $2.9
Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript
12:44pm, Thursday, 08'th May 2025
Royalty Pharma plc (NASDAQ:RPRX ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants George Grofik - Senior Vice President and Head, Investor Relations and Communications Pab
Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say
11:30am, Thursday, 08'th May 2025
While the top- and bottom-line numbers for Royalty Pharma (RPRX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics co
Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates
09:30am, Thursday, 08'th May 2025
Royalty Pharma (RPRX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.98 per share a year ago.
Royalty Pharma Reports First Quarter 2025 Results
07:15am, Thursday, 08'th May 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics
10:21am, Monday, 05'th May 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Royalty Pharma (RPRX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 01'st May 2025
Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Royalty Pharma Declares Second Quarter 2025 Dividend
04:15pm, Monday, 21'st Apr 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ordi
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
04:15pm, Thursday, 17'th Apr 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. fin
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors
04:15pm, Tuesday, 08'th Apr 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company's Board of Directors, effective immediately. Vlad Cori
4 Healthcare Stocks With Massive Gains—and More to Come
07:16am, Saturday, 29'th Mar 2025
The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks ar
Royalty Pharma Announces Upcoming Investor Day
08:15am, Thursday, 27'th Mar 2025
NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an Investor Day in New York City on Thursday, September 11, 2025, starting at 8:30 a.m.
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference
04:15pm, Thursday, 27'th Feb 2025
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference on March 4, 2
17 Upcoming Dividend Increases, Including 3 Kings
11:03am, Thursday, 13'th Feb 2025
This week's dividend increases feature three Dividend Kings: Archer-Daniels-Midland, Consolidated Edison, and Black Hills Corporation, with streaks of 50, 51, and 55 years, respectively. Consistently
